Strategic Partnering

“Tracking Parkinson’s is world-leading in its scope and scale and one of our key ambitions, when the study was designed over a decade ago, was to share an expansive dataset and biosample repository with scientists all over the world to better understand the disease and its origins, and to develop better, targeted treatments. It is extremely rewarding after so many years of data collection to realize that ambition through collaborations with teams like Metabolon. The Tracking team is very grateful to all of our participants and their families, to our research nurses around the UK, and to our funder Parkinson’s UK for working with us all these years. We are very much looking forward to sharing the results from this exciting partnership”

VIEW COLLABORATION STORY

“Tracking Parkinson’s is world-leading in its scope and scale and one of our key ambitions, when the study was designed over a decade ago, was to share an expansive dataset and biosample repository with scientists all over the world to better understand the disease and its origins, and to develop better, targeted treatments. It is extremely rewarding after so many years of data collection to realize that ambition through collaborations with teams like Metabolon. The Tracking team is very grateful to all of our participants and their families, to our research nurses around the UK, and to our funder Parkinson’s UK for working with us all these years. We are very much looking forward to sharing the results from this exciting partnership”

VIEW COLLABORATION STORY

“When Genomics England was established over ten years ago, our horizons and goals were shaped by the technology available at the time. Since then, there have been major advances in science, technology, and analytics, including the emergence of metabolomics. We’re now looking to expand our focus to bring together these different ‘omics approaches to build the world’s largest dataset with comprehensive multi-omic profiling for rare disease. We’re excited to work with Metabolon to bring this vision to life and explore the potential for metabolomic profiling to improve our understanding of the causes of rare conditions to support diagnosis for patients and families affected by rare genetic conditions.”

VIEW COLLABORATION STORY

“This is an important, timely, and welcomed partnership between LKCMedicine and Metabolon, a major international biotechnology company, on the HELIOS study. The collaboration will enable researchers at LKCMedicine and our partner academic organizations to better understand the functional disturbances that may lead to diabetes, heart disease, and other chronic conditions of high public health importance. As one of the most comprehensive studies of metabolic regulation in Asian populations, the results will provide major new insights into the determinants of health, with findings of direct relevance to Singapore.”

VIEW COLLABORATION STORY

“UMSOM has worked with the Amish community since 1995. Through this partnership, UMSOM investigators have collected blood and tissue samples that have provided powerful insights into health and disease, including how this group responds to an array of cardiovascular treatments. Our partnership with Metabolon offers a rare opportunity to leverage metabolomics to biochemically profile a genetically unique population and more deeply understand the basics of incidental disease.”

VIEW COLLABORATION STORY

“We have been working with Metabolon successfully for many years and we are excited to bring this collaboration to the next level. We believe this will lead to exciting new insights into health and disease.”

VIEW COLLABORATION STORY

“By enhancing the Canadian Longitudinal Study on Aging with data on frailty biomarkers, researchers will be able to ask questions not only about the basic science of frailty, but how that ties into the physical, psychological and social impacts of being frail.”

VIEW COLLABORATION STORY

“Over 60 percent of U.S. women are unable to achieve their lactation goals, and the variability in human breastmilk has been understudied. Leveraging techniques such as metabolomics will be critical to moving forward the field of lactation science and optimizing care for every mother and infant.”

VIEW COLLABORATION STORY